gip and glp-1 receptor agonist New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity Overweight Comparison between GLP-1 RA and
Description
Dyslipidemia in obesity: mechanisms and potential targets
Its efficacy and safety were evaluated in a 56-week, randomized, placebo-controlled trial involving adolescents aged 12 to 18 years with obesity
Preparing for your first semaglutide GLP-1 injection can help ensure a smooth and comfortable start to your weight loss journey
Maternal exercise intervention in obese pregnancy improves the cardiovascular health of the adult male offspring
[DOI] [PubMed] [Google Scholar] 34
Weight-loss surgery effectively reduces weight and complications in patients with severe obesity
